Delivery Order SPE2DB22D9353-SPE2DB23FX1SQ

The Defense Logistics Agency Troop Support Medical awarded a $19,518.56 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561421761 TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance is Park Ridge, Illinois. The period of performance is July 5, 2023 through July 26, 2023. This delivery order was issued against an unidentified medical supply vehicle to provide Tysabri, a drug used to treat multiple sclerosis and Crohn's disease. No subcontractors or set aside...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $51,095.52 contract is for the delivery of TYSABRI 300 MG/15 ML VIAL 15ML, a specialized pharmaceutical product. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a wide range...

The Defense Logistics Agency awarded a $4,879 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply TYSABRI 300 MG/15 ML VIAL pharmaceutical products. The order is being fulfilled under an existing prime vendor contract vehicle and supports DLA's medical supply procurement programs. DMS will deliver the TYSABRI products to a customer located in Park Ridge, Illinois by July 28, 2023, fulfilling requirements originally requested through this agency. No subcontractors or set...

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of TYSABRI 300 MG/15 ML VIAL 15ML, with a completion date of March 12, 2024 and a firm fixed price of $41,265.44. This contract does not have a set-aside designation. The contract is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at fourteen thousand six hundred thirty-eight dollars and ninety-two cents ($14,638.92) to DMS Pharmaceutical Group Inc. to supply 4562100532 TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance will be in Park Ridge, Illinois. The period of performance is from September 6, 2023 through September 27, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,518 to DMS Pharmaceutical Group Inc. to supply TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance is Park Ridge, Illinois. The period of performance is from August 10, 2023 through August 31, 2023. As the DLA supports the logistical needs of the Department of Defense, this delivery order is likely providing a pharmaceutical product in support of DOD medical treatment programs over the...

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TYSABRI 300 MG/15 ML VIAL 15ML, a pharmaceutical product, with a ceiling value of $5,262.76 and a period of performance through May 27, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the...

The Defense Logistics Agency awarded a delivery order valued at $17,597.05 to AmerisourceBergen Drug Corp for AVONEX Pen 30 MCG/0.5 ML (4-pack) on November 5, 2025, with a completion date of November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled...

This federal contract award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a prescription medication, to the U.S. government. The $23,118.08 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on April 30, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The contract is not a...

This is a $23,118.08 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a prescription medication. Amerisourcebergen, a leading pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...